
Vaxcyte (PCVX) Market Capitalization Overview
Market Cap: $4.46B as of Jun 13, 2025
$4.46B
Past Month+$472.16M (11.84%)
As of Jun 13, 2025, Vaxcyte (PCVX) has a market capitalization of $4.46B. Over the past 30 days, its market cap has decreased by -0.62%, while in the last 12 months, it has decreased by -56.3%.
Market capitalization represents the total value of Vaxcyte as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Vaxcyte (PCVX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Vaxcyte (PCVX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Vaxcyte as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Vaxcyte (PCVX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Vaxcyte (PCVX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Vaxcyte (PCVX) Market Cap & Key Trends
See Vaxcyte’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Vaxcyte (PCVX)
Order type
Buy in
Order amount
Est. shares
0 shares
Vaxcyte (PCVX) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $4.52B | -0.62% |
May 1, 2025 | $4.55B | +9.54% |
Apr 1, 2025 | $4.15B | -55.30% |
Mar 3, 2025 | $9.29B | -12.17% |
Feb 3, 2025 | $10.58B | +1.81% |
Jan 2, 2025 | $10.39B | -9.06% |
Vaxcyte (PCVX) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $4.46B | -56.30% |
2024 | $10.21B | +70.74% |
2023 | $5.98B | +57.79% |
2022 | $3.79B | +201.58% |
2021 | $1.26B | -7.24% |
2020 | $1.36B | — |
FAQs About Vaxcyte (PCVX) Market Cap
As of Jun 13, 2025, the market capitalization of Vaxcyte (PCVX) is $4.46B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Vaxcyte’s market capitalization has increased by 11.84%, changing from $3.99B to $4.46B as of Jun 13, 2025.
In the last 3 months, Vaxcyte’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Vaxcyte’s market capitalization increased from $5.98B in January to $10.21B in December, reflecting a 70.74% change.
In the past five years, Vaxcyte (PCVX) has had a compound annual growth rate (CAGR) of 49.77% in market capitalization. This means its market cap has grown at an average rate of 49.77% per year.